Inventor
BURKE JR TERRENCE R
US20 patents
⚠️ This page may combine multiple inventors who share the name “BURKE JR TERRENCE R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
13 patentsUS4775759AOct 4, 1988
Synthesis and utilization of 17-methyl and 17-cyclopropylmethyl-3,14-dihydroxy-4,5α-epoxy 6β-fluoromorphinans (foxy and cyclofoxy) as (18F)-labeled opioid ligands for position emission transaxial tomography (PETT)
US HEALTH46 citations90
US6307090B1Oct 23, 2001
Acylated oligopeptide derivatives having cell signal inhibiting activity
US HEALTH15 citations82
US5200546AApr 6, 1993
Phosphonoalkyl phenylalanine compounds suitably protected for use in peptide synthesis
US HEALTH20 citations78
US5688992ANov 18, 1997
O-malonyltryrosyl compounds, O-malonyltryrosyl compound-containing peptides, and use thereof
US HEALTH14 citations68
US5610185AMar 11, 1997
Method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds
US HEALTH13 citations68
US6977241B2Dec 20, 2005
SH2 domain binding inhibitors
US HEALTH3 citations60
US7132392B1Nov 7, 2006
Inhibition of cell motility and angiogenesis by inhibitors of Grb2-SH2-domain
US HEALTH2 citations55
US10208035B2Feb 19, 2019
Compounds for inhibiting drug-resistant strains of HIV-1 integrase
US HEALTH0 citations47
US9676771B2Jun 13, 2017
Compounds for inhibiting drug-resistant strains of HIV-1 integrase
US HEALTH0 citations47
US7425537B2Sep 16, 2008
SH2 domain binding inhibitors
US HEALTH1 citations46
US7871981B2Jan 18, 2011
Inhibition of cell motility, angiogenesis, and metastasis
US HEALTH0 citations42
US7825216B2Nov 2, 2010
Phenylanine derivatives
US HEALTH0 citations40
US7767645B2Aug 3, 2010
SH2 domain binding inhibitors
US HEALTH0 citations36
US ARMY
2 patentsBURKE JR TERRENCE R
2 patentsTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES
2 patentsUS10905769B2Feb 2, 2021
Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use
THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES0 citations38
US10047122B2Aug 14, 2018
Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use
THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES0 citations37